FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
114,331,829
Total 13F shares
87,813,890
Share change
+1,963,258
Total reported value
$3,509,314,003
Put/Call ratio
118%
Price per share
$39.97
Number of holders
210
Value change
+$84,938,020
Number of buys
117
Number of sells
82

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2020

As of 30 Sep 2020, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 210 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,813,890 shares. The largest 10 holders included Redmile Group, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Johnson & Johnson Innovation - JJDC, Inc., JANUS HENDERSON GROUP PLC, FARALLON CAPITAL MANAGEMENT LLC, Casdin Capital, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC. This page lists 210 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.